Skip to main content
Livermore
Livermore
ZHEN

Fortis Capital Advisors, LLC

SEC CIK
0001959790
Latest filing
Jul 31, 2026

The latest 13F from Fortis Capital Advisors, LLC covers Q2 2026 (filed Jul 31, 2026): 408 long positions worth $889.4M. The top 10 holdings make up 37.7% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 5.8%. Livermore has 15 filings on Form 13F from this institution, going back to Q4 2022.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
98
Est. +$69.9M
Added
157
Est. +$50.7M
Reduced
127
Est. −$50.1M
Sold out
61
Est. −$47.8M

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    5.8%$51.7MHistory
  2. Invesco QQQ Trust Series I46090E103
    5.4%$47.6M
  3. Schwab U.S. Large-Cap ETF808524201
    4.1%$36.6M
  4. SPYSPDR S&P 500 ETF Trust
    4.1%$36.4MHistory
  5. Schwab Fundamental U.S. Large Company ETF808524771
    4.0%$35.7M

Share of portfolio

Top 5 holdings and the other 403 positions, by share of portfolio value

  1. NVDA5.8%
  2. Invesco QQQ Trust Series I5.4%
  3. Schwab U.S. Large-Cap ETF4.1%
  4. SPY4.1%
  5. Schwab Fundamental U.S. Large Company ETF4.0%
  6. Other 403 positions76.6%

Biggest buys

New and added positions, by estimated amount bought

  1. PFGCPerformance Food Group Co
    +$3.10MNewHistory
  2. NVDANVIDIA Corp
    +$2.94MAddedHistory
  3. INCYIncyte Corp
    +$2.88MNewHistory
  4. TGTXTG Therapeutics, Inc.
    +$2.79MNewHistory
  5. Invesco Exchange Traded FD T46137V498
    +$2.38MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Invesco QQQ Trust Series I46090E103
    +0.67 pp4.7% → 5.4%
  2. ALABAstera Labs, Inc.
    +0.44 pp0.2% → 0.6%History
  3. PFGCPerformance Food Group Co
    +0.35 pp0.0% → 0.3%History
  4. INCYIncyte Corp
    +0.32 pp0.0% → 0.3%History
  5. TGTXTG Therapeutics, Inc.
    +0.31 pp0.0% → 0.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. State Street SPDR Bloomberg 1-3 Month T-Bill ETF78468R663
    −$13.2MReduced
  2. MRVLMarvell Technology, Inc.
    −$3.00MReducedHistory
  3. AMDAdvanced Micro Devices Inc
    −$2.85MReducedHistory
  4. NBISNebius Group N.V.
    −$2.79MReducedHistory
  5. ADMArcher-Daniels-Midland Co
    −$2.78MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. State Street SPDR Bloomberg 1-3 Month T-Bill ETF78468R663
    −1.84 pp2.5% → 0.7%
  2. NFLXNetflix Inc
    −0.40 pp0.8% → 0.4%History
  3. ADMArcher-Daniels-Midland Co
    −0.36 pp0.4% → 0.0%History
  4. iShares Tr464287390
    −0.32 pp0.4% → <0.1%
  5. PLTRPalantir Technologies Inc.
    −0.31 pp1.0% → 0.7%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$889.4M
+$126.0M (+16.5%) vs. prior quarter
Positions
408
+37 vs. prior quarter
Top 10 concentration
37.7%
Top 10 as share of value
Turnover
11.9%
Q2 2026, one quarter
Average holding period
8.8 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2022), so positions held before then are understated.

13F filings by quarter

15 quarters, going back to Q4 2022. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $889.4M (Q2 2026)

Q4 2022: $167.8MQ1 2023: $186.7MQ2 2023: $170.5MQ3 2023: $156.0MQ4 2023: $179.8MQ1 2024: $237.6MQ2 2024: $277.1MQ3 2024: $299.1MQ4 2024: $292.7MQ1 2025: $492.5MQ2 2025: $559.1MQ3 2025: $631.1MQ4 2025: $677.4MQ1 2026: $763.4MQ2 2026: $889.4M
Q4 2022Q2 2026
13F filings of Fortis Capital Advisors, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 31, 2026408$889.4MNVDAInvesco QQQ Trust Series ISchwab U.S. Large-Cap ETFvs. Q1 2026SEC
Q1 2026Apr 28, 2026371$763.4MNVDAInvesco QQQ Trust Series ISchwab U.S. Large-Cap ETFvs. Q4 2025SEC
Q4 2025Jan 27, 2026311$677.4MNVDASchwab U.S. Large-Cap ETFInvesco QQQ Trust Series Ivs. Q3 2025SEC
Q3 2025Oct 31, 2025283$631.1MNVDAInvesco QQQ Trust Series ISchwab U.S. Large-Cap ETFvs. Q2 2025SEC
Q2 2025Jul 21, 2025240$559.1MNVDAInvesco QQQ Trust Series ISchwab U.S. Large-Cap ETFvs. Q1 2025SEC
Q1 2025May 20, 2025249$492.5MSPYSchwab Fundamental U.S. Large Company ETFSchwab U.S. Large-Cap ETFvs. Q4 2024SEC
Q4 2024Feb 13, 2025172$292.7MSPYInvesco QQQ Trust Series INVDAvs. Q3 2024SEC
Q3 2024Nov 13, 2024172$299.1MSPYInvesco QQQ Trust Series INVDAvs. Q2 2024SEC
Q2 2024Aug 2, 2024159$277.1MSPYInvesco QQQ Trust Series INVDAvs. Q1 2024SEC
Q1 2024May 8, 2024159$237.6MSPYInvesco QQQ Trust Series INVDAvs. Q4 2023SEC
Q4 2023Feb 12, 2024113$179.8MSPYInvesco QQQ Trust Series IAAPLvs. Q3 2023SEC
Q3 2023Nov 15, 2023102$156.0MSPYInvesco QQQ Trust Series IAAPLvs. Q2 2023SEC
Q2 2023Aug 15, 2023106$170.5MSPYInvesco QQQ Trust Series IAAPLvs. Q1 2023SEC
Q1 2023May 15, 2023644$186.7MSPYInvesco QQQ Trust Series IState Street SPDR Bloomberg 1-3 Month T-Bill ETFvs. Q4 2022SEC
Q4 2022Feb 14, 2023659$167.8MSPYState Street SPDR Bloomberg 1-3 Month T-Bill ETFInvesco QQQ Trust Series I–SEC